Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Arbutus Biopharma (ABUS)
- 4.150
- -0.150-3.49%
Close Apr 10 16:00 ET
- 4.196
- +0.046+1.10%
Post 20:01 ET
811.23MMarket Cap-24.41P/E (TTM)
4.330High4.130Low2.67MVolume4.310Open4.300Prev Close11.25MTurnover2.10%Turnover RatioLossP/E (Static)195.48MShares5.10052wk High10.59P/B529.89MFloat Cap2.94052wk Low--Dividend TTM127.68MShs Float31.480Historical High--Div Yield TTM4.65%Range %0.821Historical Low4.207Avg Price1Lot Size
Arbutus Biopharma (ABUS) Key Financial Indicators
ABUS Earnings per Share (EPS)
According to the latest financial report of Arbutus Biopharma, the latest earnings per share (TTM) for the company is -0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ABUS Free Cash Flow (FCF)
Interested in knowing about Arbutus Biopharma's free cash flow? The latest report shows it as -4.68M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ABUS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Arbutus Biopharma shows that the company's current ratio is 15.73, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ABUS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Arbutus Biopharma, the quick ratio is 15.47, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ABUS Return on Equity (ROE)
Want to learn more about the financial health of Arbutus Biopharma? The latest ROE figure is -4.88%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ABUS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Arbutus Biopharma, the total asset return on investment (ROA) is -3.91%.
Currency: USD
Quarterly
Loading...
ABUS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Arbutus Biopharma's latest financial report to see how their gross margin is doing - currently at -5.30%.
Currency: USD
Quarterly
Loading...
ABUS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Arbutus Biopharma, the net profit margin is -357.37%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm